Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease

por Zimmer, Jennifer A., Shcherbinin, Sergey, Devous, Michael D., Bragg, Sonja M., Selzler, Katherine J., Wessels, Alette M., Shering, Craig, Mullen, Jamie, Landry, John, Andersen, Scott W., Downing, AnnCatherine M., Fleisher, Adam S., Svaldi, Diana Otero, Sims, John R.
Publicado 2021

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

por Wessels, Alette M., Tariot, Pierre N., Zimmer, Jennifer A., Selzler, Katherine J., Bragg, Sonja M., Andersen, Scott W., Landry, John, Krull, James H., Downing, AnnCatherine M., Willis, Brian A., Shcherbinin, Sergey, Mullen, Jamie, Barker, Peter, Schumi, Jennifer, Shering, Craig, Matthews, Brandy R., Stern, Robert A., Vellas, Bruno, Cohen, Sharon, MacSweeney, Emer, Boada, Mercè, Sims, John R.
Publicado 2020

Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project

por Boada, Mercè, Rodrigo, Adrián, Jessen, Frank, Wimblad, Bengt, Kramberger, Milica G., Visser, Pieter Jelle, Simó, Rafael, Rodríguez‐Gomez, Octavio, Ciudin, Andreea, Georges, Jean, Dumas, Annete, Maguire, Peggy, Krivec, David, Wimo, Anders, Valero, Sergi, Alegret, Montserrat, Jamilis, Laura, Zwan, Marissa, Sannemann, Lena, Arrufat, Jordi, Stomrud, Erik, Johansson, Gunilla, Shering, Craig, Glaysher, Bridget, Stewart, Neil, Belger, Mark, Iradier, Fatima, Campo, Laura
Publicado 2021